Edgewise Therapeutics Q3 net income USD 1,166.151 million

EWTX•2026-11-04

Edgewise Therapeutics reported Q3 net income of USD 1,166.151 million and basic EPS of USD 10.71. Operating income was USD -46.143 million, with operating expenses of USD 46.143 million.

1. Quarterly results

Edgewise Therapeutics reported Q3 net income of USD 1,166.151 million and basic EPS of USD 10.71. Q3 operating income was USD -46.143 million, while operating expenses were USD 46.143 million.

Edgewise Therapeutics Q3 net income USD 1,166.151 million

1. Quarterly results

Related News

Service Properties Trust announces availability of Q3 2026 financial results release

Global Net Lease Q3 2026 AFFO falls 9% year over year to $48.31 million

Central Securities declares year-end distribution of $3.00 per share

Watts Water Technologies Q3 sales, adjusted EPS beat estimates

MongoDB awards Chief Accounting Officer Kong Phan 6,027 restricted stock units